Department of Finance: in principle, we must purchase domestic instruments and strictly restrict the import

On August 24, the Department of finance of Guangdong Province issued a letter on the reply to the proposal No. 20200567 of the third session of the 12th CPPCC Provincial Committee, in which the proposal on supporting the promotion and application of domestic large-scale medical equipment has been comprehensively reviewed by the Provincial Department of science and technology, the Provincial Department of industry and information technology, and the provincial health commission

Article 13 of the guiding opinions of the general office of the State Council on promoting the healthy development of the pharmaceutical industry (GBF [2016] No. 11) stipulates that if the domestic drugs and medical devices can meet the requirements, the government procurement projects must purchase domestic products in principle, and gradually improve the allocation level of domestic equipment of public medical institutions.

Last year, the Provincial Department of science and technology, together with the Guangdong Provincial Health Commission and the provincial drug administration, issued special guidelines for key research and development plans of "high-end medical devices", focusing on supporting the breakthrough of key technical bottlenecks restricting the innovation and development of the industry in the fields of medical imaging equipment, advanced treatment equipment, biomedical materials and implantable devices, in vitro diagnostic equipment and reagents Equipment and devices with independent intellectual property rights, core components, new biological materials, etc., further strengthen the characteristics and advantages of Guangdong Province in the field of medical devices.

Actively encourage public medical device users to give priority to the allocation of class B large-scale domestic brand medical equipment, and gradually improve the allocation level of domestic medical equipment. The Provincial Department of science and technology, together with the Provincial Health Commission and other nine departments, jointly issued the "several policies and measures on promoting the innovation and development of biomedicine", encouraging medical institutions in Guangdong to increase the proportion of purchasing innovative drugs and medical devices with definite curative effect, controllable quality and stable supply.